Cronos Group Terminates Material Definitive Agreement
Ticker: CRON · Form: 8-K · Filed: May 28, 2024 · CIK: 1656472
| Field | Detail |
|---|---|
| Company | Cronos Group Inc. (CRON) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, material-event
Related Tickers: CRON
TL;DR
CRON terminated a big deal, investors need to know why.
AI Summary
Cronos Group Inc. announced on May 28, 2024, the termination of a material definitive agreement. The company, formerly known as PharmaCan Capital Corp., is based in Toronto, Ontario, Canada, and operates in the medicinal chemicals and botanical products sector.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's financial standing and future business operations, requiring investors to assess the reasons and consequences.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement can introduce uncertainty and potential financial repercussions for the company.
Key Players & Entities
- Cronos Group Inc. (company) — Registrant
- PharmaCan Capital Corp. (company) — Former company name
- May 28, 2024 (date) — Date of report and earliest event
- Toronto, Ontario (location) — Principal executive offices
FAQ
What was the specific material definitive agreement that Cronos Group Inc. terminated?
The filing states the termination of a material definitive agreement but does not specify which agreement it is.
When did the termination of the material definitive agreement become effective?
The filing indicates the date of the earliest event reported is May 28, 2024, which is also the date of the report.
What is the business address of Cronos Group Inc.?
The business address is 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1.
What was Cronos Group Inc. formerly known as?
Cronos Group Inc. was formerly known as PharmaCan Capital Corp.
What is the SIC code for Cronos Group Inc.?
The Standard Industrial Classification (SIC) code for Cronos Group Inc. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Filing Stats: 700 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-28 17:02:27
Filing Documents
- cron-20240528.htm (8-K) — 30KB
- a240524staynersaleterminat.htm (EX-99.1) — 8KB
- 0001656472-24-000071.txt ( ) — 158KB
- cron-20240528.xsd (EX-101.SCH) — 2KB
- cron-20240528_lab.xml (EX-101.LAB) — 20KB
- cron-20240528_pre.xml (EX-101.PRE) — 12KB
- cron-20240528_htm.xml (XML) — 3KB
02. Termination of a Material Definitive Agreement
Item 1.02. Termination of a Material Definitive Agreement. On May 28, 2024, the agreement (the "Sale Agreement") by and between a wholly owned subsidiary of Cronos Group Inc. (the "Company") and Future Farmco Canada Inc. (the "Buyer") for the sale and leaseback of the Company's real property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the "Peace Naturals Campus") terminated pursuant to its terms. The Buyer did not satisfy or waive its condition that it satisfied itself in its sole, absolute and subjective discretion with respect to all aspects of the property, including financing of the purchase price, on or before May 27, 2024, the first business day that was 180 calendar days following the date of the Sale Agreement. All amounts paid by Buyer as part of a security deposit that were previously held in trust have been returned to the Buyer, in accordance with the Sale Agreement.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On May 28, 2024, the Company issued a press release announcing the termination of the Sale Agreement. A copy of the press release is attached as Exhibit 99.1 to, and is incorporated by reference in, this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Cronos Group Inc., dated May 28, 2024 . 104 Cover Page Interactive Data File – The cover page from Cronos Group Inc.'s Current Report on Form 8-K filed on May 28, 2024 is formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CRONOS GROUP INC. Dated: May 28, 2024 By: /s/ Michael Gorenstein Name: Michael Gorenstein Title: President and Chief Executive Officer